Prophylactic Effectiveness of Tobramycin-Dexamethasone Eye Drops Compared with Tobramycin/Vehicle Eye Drops in Controlling Post-Surgical Inflammation in Cataract Patients

Ricardo Notivol; Dina Amin; Anna Whitling; David Wells; Margaret Kennedy; Paul C. Cockrum; The International TobraDex Study Group


Clin Drug Invest. 2004;24(9) 

In This Article


TobraDex®, when administered the day before and continued for 21 days after surgery, was superior to Tobrex®/vehicle in controlling post-cataract surgical inflammation. TobraDex® was also superior to Tobrex®/vehicle in controlling post-surgical ocular pain, and when administered four times daily was safe and well tolerated in patients treated for the prevention of post-surgical inflammation after cataract surgery.

The use of trade names is for product identification purposes only and does not imply endorsement.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.